A Canadian gold project developer and a U.S. bank holding company both received analyst upgrades, one of which has an implied upside of nearly 50%.
| Company Name | Exchange | Ticker | Last Price | Market Cap | Recommendation | Analyst Name | Rating Company | Target Price |
Upside/ Downside (%) |
|---|---|---|---|---|---|---|---|---|---|
| Tahoe Resources Inc | TSX | THO | 23.31 | 3,438.5 | Upgrade to outperform from market perform | Chris Thompson | Raymond James | 30.00 | 28.7% |
| Concordia Healthcare Corp | TSX | CXR | 36.18 | 1,033.3 | Initiate with outperform | Douglas Miehm | RBC Capital Markets | 46.00 | 27.1% |
| Polymet Mining Corp | TSX | POM | 1.20 | 330.8 | Initiate with sector outperform | Tom Meyer | CIBC World Markets | 2.00 | 66.7% |
| DHX Media Ltd | TSX | DHX | 8.58 | 1,028.5 | Downgrade to hold from strong buy | Joseph Mackay | Global Maxfin Capital Inc | 9.00 | 4.9% |
Raymond James upgraded Tahoe Resources Inc (TSX: THO), engaged in acquiring, exploring and developing precious metals, primarily silver, to outperform from market perform with a price target of C$30.00, indicating an upside of 28.7% from current levels.
RBC Capital Markets initiated coverage on Concordia Healthcare Corp (TSX: CXR), engaged in the acquisition of pharmaceutical products and medical devices, with an outperform rating assigning a 12-month price target of C$46.00, indicating an upside potential of 27.1% from current levels.
Coverage on Polymet Mining Corp (TSX: POM), engaged in the exploration and development of natural resource properties, was initiated with a sector outperform rating at CIBC World Markets, assigning a 12-month price target of C$2.00, indicating an upside potential of 66.7% from current levels.
Global Maxfin Capital Inc downgraded DHX Media Ltd (TSX: DHX), engaged in the supply and distribution of television and film productions, to hold from strong buy with a price target of C$9.00, indicating an upside of 4.9% from current levels.
| Company Name | Exchange | Ticker | Last Price | Market Cap | Recommendation | Analyst Name | Rating Company | Target Price |
Upside/ Downside (%) |
|---|---|---|---|---|---|---|---|---|---|
| Kilroy Realty Corp | NYSE | KRC | 59.63 | 4,970.9 | Upgrade to buy from neutral | Steve Sakwa | ISI Group | 67.00 | 12.4% |
| Teekay Corp | NYSE | TK | 58.36 | 4,162.7 | Upgrade to buy from hold | Amit Mehrotra | Deutsche Bank | 90.00 | 54.2% |
| Akorn Inc | NASDAQ | AKRX | 36.36 | 3,786.3 | Upgrade to outperform from sector perform | Randall S Stanicky | RBC Capital Markets | 45.00 | 23.8% |
| Blueknight Energy Partners LP | NASDAQ | BKEP | 8.15 | 266.5 | Initiate with overweight | Ben Wyatt | Stephens Inc | 9.50 | 16.6% |
| Athlon Energy Inc | NYSE | ATHL | 58.32 | 5,675.7 | Downgrade to neutral from buy | Jeffrey Connolly | Mizuho Securities USA Inc | 58.50 | 0.3% |
ISI Group upgraded Kilroy Realty Corp (NYSE: KRC), engaged in owning, acquiring, developing and operating Class A office properties located in California and Washington, to buy from neutral raising its price target to $67.00 from $66.00, indicating an upside of 12.4% from current levels.
Teekay Corp (NYSE: TK), engaged in providing international crude oil and gas marine transportation services, was upgraded by Deutsche Bank to buy from hold raising its price target to $90.00 from $68.00, indicating an upside potential of 54.2% from current levels.
RBC Capital Markets upgraded Akorn Inc (NASDAQ: AKRX), engaged in manufacturing and marketing full line of diagnostic and therapeutic ophthalmic pharmaceuticals, niche hospital drugs and injectable pharmaceuticals, to outperform from sector perform raising its price target to $45.00 from $36.00, indicating an upside of 23.8% from current levels. The rating film cites, environment in U.S. for generic drugs is good with an accelerating approval rate and strong pricing trends
Stephens Inc initiated coverage on Blueknight Energy Partners LP (NASDAQ: BKEP), engaged in providing crude oil gathering, transporting, terminalling and storing energy commodities services, with an overweight rating assigning a 12-month price target of $9.50, indicating an upside potential of 16.6% from current levels.
Athlon Energy Inc (NYSE: ATHL), engaged in exploration and production of oil and natural gas, was downgraded by Mizuho Securities USA Inc to neutral from buy with a price target of $58.50, implying an upside potential of 0.3% from current levels.
